Viant Medical Executive and Leadership Team

Dan Croteau, the Chief Executive Officer at Viant Medical, directs the overarching corporate strategy and long-term vision for the organization. By aligning technical expertise with market demands, the Chief Executive Officer ensures the company maintains a competitive edge in the medical device manufacturing sector. Croteau oversees the integration of end-to-end services, fostering partnerships with healthcare organizations to accelerate product development cycles. This leadership role involves constant evaluation of global market trends to identify growth opportunities and operational efficiencies. Dan Croteau drives the executive team toward achieving excellence in life-enhancing medical technology production. Through rigorous focus on quality standards and innovation, the Chief Executive Officer secures the company's position as a leader in the healthcare industry. Croteau maintains accountability for overall performance, ensuring that every manufacturing initiative supports the broader mission of delivering high-quality medical devices to patients worldwide.

Sharad Mallya, the Interim Chief Financial Officer at Viant Medical, governs the financial health and fiscal strategy of the organization. Managing capital allocation and budgetary planning, the Interim Chief Financial Officer ensures that resources support the company's long-term growth objectives in the medical device market. Mallya analyzes financial data to provide actionable insights for the executive team, facilitating informed decision-making regarding investments and operational expansion. This leadership role involves maintaining robust financial controls and reporting standards to ensure transparency and compliance. Sharad Mallya coordinates with other C-suite leaders to align financial goals with the broader mission of delivering innovative medical technology. By optimizing cost structures and revenue streams, the Interim Chief Financial Officer strengthens the company's market position. Mallya monitors economic indicators to mitigate risks, ensuring financial stability during periods of growth. Through disciplined fiscal management, the Interim Chief Financial Officer supports the organization's ability to invest in cutting-edge manufacturing capabilities.

Sean Crowley, the Chief Operating Officer at Viant Medical, manages the daily execution of manufacturing processes and supply chain logistics. Overseeing production facilities, the Chief Operating Officer ensures that all technical operations meet stringent regulatory requirements and quality benchmarks. Crowley optimizes internal workflows to enhance efficiency, directly impacting the speed and reliability of medical device delivery. This role requires close coordination with engineering teams to translate complex concepts into scalable manufacturing solutions. Sean Crowley monitors operational performance across all regional sites, maintaining consistency in service delivery. By streamlining resource allocation, the Chief Operating Officer supports the company's commitment to operational excellence. Crowley drives continuous improvement initiatives, ensuring that manufacturing capabilities remain at the forefront of medical technology. Through meticulous oversight of production cycles, the Chief Operating Officer guarantees that the organization meets the evolving needs of healthcare partners while maintaining high standards of precision and safety.

Jean Nagra, the President at Viant Medical, leads the commercial strategy and business development efforts to expand the company's footprint in the healthcare sector. Overseeing client relationships and market penetration, the President ensures that the organization effectively communicates its value proposition to medical device partners. Nagra drives initiatives to capture new market segments, leveraging the company's technical expertise to secure long-term contracts. This role involves collaborating with cross-functional teams to align service offerings with the specific needs of healthcare organizations. Jean Nagra monitors competitive dynamics to refine the company's approach to global markets. By fostering strong partnerships, the President enhances the organization's reputation for quality and reliability. Nagra directs the implementation of growth strategies that capitalize on the company's end-to-end integration capabilities. Through strategic leadership, the President ensures that the organization remains a preferred partner for medical device manufacturing, consistently delivering innovative solutions that improve patient care and support the company's overall mission.